The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders

NCT02192320 ↗

Phase 2 Unknown 60 enrolled Oriental Neurosurgery Evidence-Based-Study Team

RandomizedParallel-groupSingle-blindTreatment

Summary

To evaluate Efficacy and Safety of oral Atorvastatin and Dexamethasone on conservative treatment for Chronic Subdural Hematoma (CSDH) patients with Coagulation Disorders

Timeline

Start: 2014-07
Primary completion: 2015-09
Completion: 2015-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Atorvastatin	Small molecule	20 mg	Oral
Subject	Dexamethasone	Small molecule	0.75 mg	Oral

Indications

No indication recorded.